advertisement

Topcon

Pharmaceutics 11

Showing records 1 to 11 | Display all abstracts in Pharmaceutics

100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
De Pieri A
Pharmaceutics 2022; 14:
100747 Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments
Serramito M
Pharmaceutics 2022; 14:
100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Ocorr K
Pharmaceutics 2022; 14:
100747 Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments
Pereira-da-Mota AF
Pharmaceutics 2022; 14:
100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Jerreld K
Pharmaceutics 2022; 14:
100747 Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments
Carpena-Torres C
Pharmaceutics 2022; 14:
100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Lamoca M
Pharmaceutics 2022; 14:
100747 Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments
Huete-Toral F
Pharmaceutics 2022; 14:
100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Hitzl W
Pharmaceutics 2022; 14:
100747 Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments
Alvarez-Lorenzo C; Carracedo G
Pharmaceutics 2022; 14:
100383 Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Wuertz-Kozak K
Pharmaceutics 2022; 14:

Issue 23-1

Change Issue


advertisement

Oculus